USP28
Basic information
Region (hg38): 11:113797874-113875572
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP28 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 53 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 2 | 1 |
Variants in USP28
This is a list of pathogenic ClinVar variants found in the USP28 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-113799350-C-T | not specified | Uncertain significance (Apr 08, 2022) | ||
11-113799392-C-G | not specified | Uncertain significance (Oct 06, 2021) | ||
11-113799400-C-T | not specified | Uncertain significance (Apr 13, 2023) | ||
11-113801625-T-A | Benign (Aug 03, 2017) | |||
11-113803174-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
11-113803190-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
11-113803198-T-A | not specified | Uncertain significance (Mar 06, 2023) | ||
11-113803207-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
11-113803208-G-A | not specified | Uncertain significance (May 24, 2023) | ||
11-113803217-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
11-113803221-C-G | not specified | Uncertain significance (May 18, 2023) | ||
11-113803250-C-T | not specified | Uncertain significance (Sep 04, 2024) | ||
11-113803851-G-T | not specified | Uncertain significance (Aug 04, 2023) | ||
11-113804722-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
11-113804747-T-C | not specified | Uncertain significance (Apr 29, 2024) | ||
11-113806508-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
11-113806543-T-C | not specified | Uncertain significance (Apr 24, 2024) | ||
11-113806566-T-A | not specified | Uncertain significance (Jan 10, 2023) | ||
11-113806566-T-C | not specified | Uncertain significance (Nov 11, 2024) | ||
11-113808338-C-T | not specified | Likely benign (May 26, 2022) | ||
11-113808386-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
11-113808437-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
11-113809158-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
11-113809167-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
11-113809182-T-C | not specified | Uncertain significance (Apr 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP28 | protein_coding | protein_coding | ENST00000003302 | 25 | 77697 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.53e-13 | 1.00 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 484 | 563 | 0.860 | 0.0000286 | 7074 |
Missense in Polyphen | 159 | 219.38 | 0.72478 | 2796 | ||
Synonymous | 0.538 | 191 | 201 | 0.952 | 0.0000101 | 2020 |
Loss of Function | 3.93 | 32 | 66.7 | 0.480 | 0.00000395 | 734 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000818 | 0.000815 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000389 | 0.000387 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells (PubMed:24623306). {ECO:0000269|PubMed:16901786, ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:17873522, ECO:0000269|PubMed:18662541, ECO:0000269|PubMed:24623306}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.763
- rvis_EVS
- -0.79
- rvis_percentile_EVS
- 12.6
Haploinsufficiency Scores
- pHI
- 0.608
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.725
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp28
- Phenotype
- immune system phenotype; hematopoietic system phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- usp28
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curled
Gene ontology
- Biological process
- DNA damage checkpoint;DNA repair;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;Ras protein signal transduction;cell population proliferation;response to ionizing radiation;protein deubiquitination;regulation of protein stability;cellular response to UV;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- Cellular component
- nucleoplasm;cytosol;nuclear body;protein-containing complex
- Molecular function
- cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;thiol-dependent ubiquitinyl hydrolase activity